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Dissociation of human -2-microglobulin (2m) from the heavy
chain of the class I HLA complex is a critical first step in the
formation of amyloid fibrils from this protein. As a consequence of
renal failure, the concentration of circulating monomeric 2m
increases, ultimately leading to deposition of the protein into
amyloid fibrils and development of the disorder, dialysis-related
amyloidosis. Here we present the crystal structure of a monomeric
form of human 2m determined at 1.8-Å resolution that reveals
remarkable structural changes relative to the HLA-bound protein.
These involve the restructuring of a  bulge that separates two
short  strands to form a new six-residue  strand at one edge of
this  sandwich protein. These structural changes remove key
features proposed to have evolved to protect sheet proteins from
aggregation [Richardson, J. & Richardson, D. (2002) Proc. Natl. Acad.
Sci. USA 99, 2754–2759] and replaces them with an aggregation-
competent surface. In combination with solution studies using 1H
NMR, we show that the crystal structure presented here represents
a rare species in solution that could provide important clues about
the mechanism of amyloid formation from the normally highly
soluble native protein.
Beta-2-microglobulin (2m) constitutes the noncovalentlybound light chain of the class I human leukocyte antigen
(HLA class I). The protein is 99 residues in length and has a
seven-stranded  sandwich fold typical of the Ig superfamily (1).
In vivo, 2m is continuously shed from the surface of cells
displaying HLA class 1 molecules into the serum, where it is
transported to the kidneys to be degraded and excreted. As a
consequence of renal failure, the concentration of 2m circu-
lating in the serum increases up to 60-fold (2). Free 2m then
associates to form amyloid fibrils that typically accumulate in the
musculoskeletal system and result in the development of the
disorder dialysis-related amyloidosis. The majority of ex vivo 2m
amyloid is comprised of full-length wild-type 2m, although
small amounts (30%) of modified or truncated forms are found
(2–4).
As for other amyloidogenic proteins (5–7), mild acidification
has been shown to promote formation of amyloid fibrils in vitro
from pure 2m, both de novo (8–10) and by extension of ex vivo
material (11). Under acidic conditions, high yields of amyloid-
like fibrils displaying a variety of morphologies form spontane-
ously in vitro (8–10). Incubation of 2m at pH 3.6 results in the
formation of a partially unfolded species that assembles into
short curly fibrils 10 nm wide and 200 nm in length. By
contrast, fibrils with a long straight morphology, more reminis-
cent of ex vivo amyloid, are generated by incubation of acid-
denatured forms of the protein at low ionic strengths at pH 2.5
and below, either alone (10) or in the presence of fibrillar seeds
(11). Amyloid fibrils of 2m have also been generated in vitro at
neutral pH by deletion of the N-terminal 6 residues (12);
incubation of the full length protein in the presence of Cu2 ions
(13); dialysis of the protein at neutral pH into H2O followed by
its concentration by drying onto the membrane surface (14); and
by the extension of ex vivo material, believed to proceed by the
assembly of a rarely populated intermediate onto the ends of
existing fibrillar seeds (11, 15). The common theme to emerge
from these studies is that conformational rearrangements of the
normally highly soluble native protein are required for amyloid
fibrils to form.
More than 80 crystal structures of human 2m bound to the
heavy chain of the class I HLA complex (HLA2m) have been
solved to date (16). These structures all display the classical
seven-stranded  sandwich fold typical of the Ig superfamily (1).
 strands A, B, D, and E comprise one  sheet, whereas  strands
C, F, and G form the second  sheet (Fig. 1c). The protein is
stabilized by a single disulphide bond between Cys-25 and
Cys-80, which links the two  sheets (1, 9, 17). In addition, the
protein contains a short (two-residue) C  strand that is located
in the loop connecting strands C and D. The fourth  strand (D),
which lies at one edge of the  sandwich, is divided into two short
two-residue  strands (D1 and D2) by a two-residue  bulge. The
distortion from regularity of a  strand at the edge of a 
sandwich is a common feature of  sheet proteins which,
together with conserved inwardly pointing charges, has recently
been proposed to prevent edge-to-edge aggregation of normally
soluble  sheet proteins (18).
Despite the wealth of structures of HLA2m, the only crystal
structure of monomeric 2m solved to date is that of the closely
related bovine protein (MB2m) (76% identity to human 2m)
(19). In a recent study, the conformational properties of mono-
meric human 2m (MH2m) in solution were determined by
using 1H NMR at pH 6.6, 33°C (20). These data showed that the
protein has the expected seven-stranded  sandwich fold, con-
sistent with earlier observations (1, 21), although residues 53–62
(the  bulge, strand D2, and its succeeding loop) are dynamic
and not uniquely structured in solution (20, 21). In addition,
changes in the structure of the loop linking strands A and B were
observed.
Here, we report the crystal structure of MH2m that reveals
structural changes relative to both HLA2m and MH2m in
solution. Combined with additional solution studies using 1H
NMR, we show that the conformation of MH2m in the crystal
represents a rarely populated species in solution that could be
important in the generation of amyloid fibrils.
Materials and Methods
Materials. Escherichia coli strain BL21(DE3) was obtained from
Promega; Q-Sepharose and all other reagents were purchased
from Sigma; Butyl-Sepharose and Superdex 75 were purchased
from Amersham Bioscience, Littie Chalfont, U.K.; and Carben-
icillin was from Melford Chemicals, Ipswich, U.K.
Abbreviations: 2m, -2-microgloblin; MH2m, monomeric human 2m; MB2m, mono-
meric bovine 2m; HLA2m, human 2m bound to the HLA class 1 complex; HSQC, hetero-
nuclear single quantum correlation; NOE, nuclear Overhauser effect; NOESY, NOE
spectroscopy.
Data deposition: The atomic coordinates have been deposited in the Protein Data Bank,
www.rcsb.org (PDB ID code 1LDS).
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2m Overexpression and Purification. Monomeric human 2m was
expressed from the plasmid pINKwt and purified as previously
described (8). The protein was shown to be 99% pure by
SDSPAGE and of the expected molecular weight by electro-
spray ionization MS (11,860  0.72 Da).
Crystal Structure Determination. Crystals of monomeric 2m were
grown as thin plates at 16°C by the sitting-drop vapor diffusion
method from a precipitant buffer solution containing 4–8%
(wtvol) polyethylene glycol 4000, 20% (volvol) isopropanol in
100 mM sodium citrate at pH 5.7. The inclusion of isopropanol
is essential for crystal formation. Crystals belong to space group
C2 with unit cell dimensions a  77.4 Å, b  29.1 Å, c  54.6
Å and   121.6°. Data collection was carried out at 100 K
by using 25% glycerol, 20% sucrose, and 10% xylitol as a
cryoprotectant.
X-ray diffraction data were collected to 1.8-Å resolution on
station 14.2 at Daresbury Synchrotron Radiation Source by using
an Area Detector System Corporation (ADSC, Poway, CA)
Quantum IV charge-coupled device detector. The data were
integrated by using MOSFLM (22), then scaled and reduced by
using SCALA and TRUNCATE from the CCP4 program suite (23).
The molecular replacement program AMORE (24) was used to
solve the structure by using data from 8.0 to 3.0-Å resolution.
The search model was based on the coordinates of 2m in the
HLA class 1 complex (Protein Data Bank ID code 1DUZ) (25).
The R factor and correlation coefficient for the best solution
were 48.0 and 45.4%, respectively.
The model was built by using the program O (26) and refined by
using CNS (27, 28) with data to 1.8-Å resolution. Progress of the
refinement was monitored by means of the free R factor (29).
Water molecules were included in the model once the R factor
reached 30%, but only where clear peaks were present in both
the 2Fo Fc and Fo Fc maps, and where appropriate hydrogen
bonds could be made to surrounding residues or other water
molecules. Refinement was judged complete when the R factor
had converged to 18.8% (Rfree  23.4%), and no significant
interpretable features remained in the Fo  Fc map. The
geometry of the model was monitored by using the program
PROCHECK (30), the Ramachandran plot showing that 98% of the
residues lie in the allowed region. A summary of the refinement
statistics is given in Table 1. The coordinates and structure factor
amplitudes have been deposited in the Protein Data Bank (ID
code 1LDS).
NMR. For homonuclear experiments, samples of 0.8 mM 2m
were prepared at pH 5.7 in 90% H2O10% D2O or 99.9% D2O.
Additional experiments were carried out by using buffer solu-
tions containing 172 mM NaCl (the ionic strength of the crystal
growth buffer) and 20% (volvol) isopropanol-d8. No significant
differences in interresidue nuclear Overhauser effect (NOE)
patterns were observed under the different conditions examined.
1H-15N heteronuclear single quantum correlation (HSQC) ex-
periments were recorded as a function of pH on a sample of 0.4
mM protein that was uniformly labeled with 15N (31). Analytical
sedimentation velocity ultracentrifugation experiments con-
firmed that in D2O or H2O the protein is monodisperse and
monomeric. In 20% (volvol) isopropanol and 172 mM NaCl,
however,20% of the protein forms dimers or higher oligomers.
Fig. 1. Ribbon diagram of the crystal structures of (a) MH2m and (c)
HLA2m. Detailed views of the conformation of residues 49–68 are also shown
for (b) MH2m and (d) HLA2m. The structure of HLA2m was taken from PDB
ID code 1DUZ (25). Individual  strands are labeled A although G. a and c were
drawn by using the program MOLSCRIPT (37) and RASTER 3D (38) and b and d, by
using SPOCK (39).
Table 1. Crystallographic data collection and
refinement statistics
Space group C2
Unit cell a  77.4 Å, b  29.1 Å, c  54.6 Å,
  121.5°
Resolution (Å) 26.7–1.8
Number of observed reflections 46,169
Number of unique reflections 9,565
Completeness (%)* 97.5 (90.6)
I(I)* 15.8 (9.6)
Rsym (%)* 3.5 (6.2)
Rfactor (%) 18.7
Rfree (%) 23.3
Number of protein atoms 809
Number of water molecules 106
Average overall B factor (Å2) 14.6
rms deviation ideal
stereochemistry
Bond lengths (Å) 0.005
Bond angles (°) 1.5
*Values given in parentheses correspond to those in the outermost shell of the
resolution range.
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These species did not perturb the spectra obtained. All NMR
experiments were performed on a Varian Inova spectrometer
operating at a 1H frequency of 500 MHz. Gradient-enhanced
HSQC spectra were acquired with 128 complex points and 8
scans per increment. Spectral windows were 1,800 Hz (15N) and
3,597 Hz (1H). Mixing times were 50 ms for the total correlation
without NOESY (TOWNY) spinlock sequence (32) in the total
correlation spectroscopy and 100 ms (D2O) or 150 ms (H2O) in
the NOE spectroscopy (NOESY). Water suppression in the
spectra acquired in H2O was achieved by adding the excitation
sculpting gradient double echo to the end of the sequences (33).
Complex points (256 	 1,024) were acquired with a spectral
window of 6,400 Hz, and 80–96 scans per increment were
collected with a relaxation delay of 1 sec. All NMR data were
processed by using NMRPIPE, Ver. 97.027.12.56 (34). The data
were apodized by using a cosine bell function, followed by zero
filling and Fourier transformation. The two-dimensional spectra
were analyzed in NMRVIEW (34). The spectra were referenced by
using 2,2-dimethyl-2-silapentane-5-sulfonic acid.
Results and Discussion
The Crystal Structure of MH2m, Crystals of MH2m grown from
pure recombinant material (see Materials and Methods) reached
170	 80	 40m and diffract to a resolution of 1.8 Å. Data were
collected from a single crystal at 100 K and the structure
determined by molecular replacement by using the structure of
its HLA-bound counterpart (PDB ID code 1DUZ) as a starting
model (see Materials and Methods). The final electron-density
map is of high quality for the entire main chain, except for the
three C-terminal residues that are disordered. As expected, the
overall structure of MH2m determined here is very similar to
that of its HLA-bound counterpart (Fig. 1). Both structures
comprise a seven-stranded antiparallel  sandwich, typical of the
Ig CH3 domain (1). Residues involved in the  strands include
A6–12, B22–30, C36–41, D51–56, E62–69, F78–83 and G91–94 for MH2m
and A6–11, B21–30, C36–41, D150–51, D255–56, E62–70, F78–83 and
G91–94 for HLA2m (Fig. 2 a and b). In addition, a short  strand
connecting strands C and D is observed (residues 44–45) in both
structures and labeled C, in accord with the  strand assign-
ments by Saper et al. (1). Superposition of all C atoms in the
crystal structures of HLA2m and MH2m gives a rms deviation
(rmsd) of 3.1 Å. The largest deviations involve residues 12–20,
49–60, and 71–77 (maximum deviation up to 13.5, 5.7, and 3.4 Å,
respectively). Omitting these regions from the alignment leads to
an rmsd of 0.5 Å. Interestingly, residues 13–18, which lie in the
loop linking strands A and B, have been shown to be dynamic in
solution (20, 21), whereas 71–77 involves a smaller movement of
the loop between strands E and F.
The most significant difference in the crystal structures of
MH2m and HLA2m involves residues in  strand D (50–56)
and the succeeding loop. When complexed with the HLA heavy
chain, residues 50–56 of HLA2m form two short (two-residue)
 strands that are separated by a two residue  bulge. These
strands (depicted as D1 and D2 in Fig. 1c) each form three
main-chain–main-chain hydrogen bonds to the adjacent  strand
E (Figs. 1d and 2b). The  bulge in HLA2m effectively twists
the edge strand, which facilitates its binding to the surface of the
heavy chain. The interface with the HLA heavy chain is stabi-
lized by numerous interactions involving residues 1, 6–12, 24–33,
53–56, 60–65, and 98–99 of HLA2m. The most significant of
these for the structure of MH2m presented here is Asp-53,
which is located in the  bulge of HLA2m and hydrogen bonds
to Gln-32, Arg-35, and Arg-48 in the 1 domain of the HLA
heavy chain.
The  bulge found in strand D is present in all of the structures
of HLA2m determined to date as well as in the crystal structure
of MB2m (19). The crystal structure of MH2m determined here
is striking in that this feature is no longer present. Instead,
residues 51–56 form a continuous six-residue  strand (Fig. 1 a
and b) that involves regular backbone  angles stabilized by
six main-chain–main-chain hydrogen bonds with  strand E,
typical of formation of a regular antiparallel  sheet. Loss of the
 bulge, together with changes in the positions of three residues
in the loop linking strands C and D, causes structural rearrange-
ments of the N-terminal section of strand D. These result in a slip
of i  1 in the hydrogen-bonding partners of residues 50–53
relative to their positions in HLA2m, with concomitant reor-
ganization of their side chains (Figs. 1 and 2). Thus, residues 50
and 52 in HLA2m form hydrogen bonds with residues 67 and
65, respectively, in strand E. By contrast, loss of the  bulge in
the crystal structure of MH2m results in residues 51 and 53
forming new hydrogen bonds with residues 67 and 65, respec-
tively (Figs. 1 and 2). The hydrogen-bonding pattern and orien-
Fig. 2. Topology diagram of the structures of (a) MH2m and (b) HLA2m showing the location of individual  strands in each structure together with their
hydrogen-bonding networks. Solid straight line depicts residues in which both the amide nitrogen and carbonyl oxygen form main-chain–main-chain hydrogen
bonds; dotted line, residues that make a main-chain–main-chain hydrogen bond involving either the amide nitrogen or the carbonyl oxygen. Data for b were
taken from PDB ID code 1DUZ (25). Strands and hydrogen bonds were determined by using the criteria of Kabsch and Sander (40).
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tation of side chains at the C-terminal end of the strand (residues
55–57) remain largely invariant in the two crystal structures.
Analysis of crystal contacts revealed a number of interactions
between neighboring molecules within the lattice. One of the two
major contacting regions is formed between residues 1–4 (N-
terminal region) of one molecule and 34–37 (loop BC and
strand C) of a neighboring molecule, forming a continuous array
throughout the lattice. This contact involves the formation of a
number of main-chain–main-chain hydrogen bonds between
adjacent monomers and buries 621 Å2 of the total 1,375 Å2
involved in the crystal contacts. The second region involves
residues 12–15 of one molecule (loop AB) and 54–57 (strand D)
of an adjacent molecule (see Fig. 5, which is published as
supporting information on the PNAS web site, www.pnas.org).
These interactions also involve the formation of intermolecular
main-chain hydrogen bonds, burying 754 Å2 and resulting in the
formation of head-to-tail dimers. In both contacts, the arrange-
ment is similar to adjacent strands in an antiparallel  sheet.
Although these contacts are in regions that undergo structural
changes in the free and bound forms, it is unlikely that they result
from the process of crystallization; rather, the changes are
required to initiate formation of the lattice.
Conformational Properties of MH2m in Solution. Previous studies
using two-dimensional 1H NMR have suggested that the con-
formation of MH2m in solution resembles closely that of its
HLA-bound counterpart (20, 21). Most intriguingly, however,
whereas the region encompassing residues 50–57 is highly or-
dered in the crystal structure of MH2m described here, this
region appears to be dynamic in solution (20, 21). To determine
whether the  bulge and its subsequent  strand (D2) persist in
MH2m in solution under the crystallization conditions, the
protein was also analyzed by using two-dimensional 1H NMR at
pH 5.7 in the presence and absence of isopropanol-d8 [20%
(volvol)] andor 172 mM NaCl to match the conditions used for
crystallization (see Materials and Methods). Backbone assign-
ments for the main-chain hydrogens in strands D and E at pH 5.7
at both 37 and 25°C were determined from those previously
obtained at pH 7.0 and 37°C (21) by carefully tracking the
resonances of 15N-labeled protein as a function of temperature
and pH. The C
 chemical shifts were then confirmed directly
by NOESY and total correlation spectroscopy experiments. By
this approach, 17 of the CH and 17 of the NH resonances from
the 20 residues between residues 50 and 69 (encompassing
strands D and E) were assigned unambiguously (the remaining
resonances including those of residues 54 and 57 showed line
broadening effects or were absent in some of the spectra). The
pattern of interstrand NOEs involving CH and NH hydrogens
in strands D and E were then used to determine the secondary
structural properties of residues 51–56 in solution. If the  bulge
comprising residues 53 and 54 is retained in solution in a major
population of molecules at pH 5.7, NOEs between the amide
hydrogens of residues 5265 and 5067, together with an NOE
between the CH hydrogens of residues 5166 should be ob-
served (Fig. 3b). However, if the conformation of MH2m in
solution is identical to that of MH2m in the crystal (i.e., the 
bulge is absent), then crosspeaks between the amide hydrogens
of residues 5365 and 5167, and between the CH hydrogens
of residues 5464 and 5266 should result (Fig. 3a). Alterna-
tively, if this region is dynamic, the spectra could be more
complex. The CH-CH and NH-NH regions of 1H-1H NOESY
spectra of MH2m obtained at pH 5.7, 37°C in D2O and H2O,
respectively, are shown in Fig. 3 c and d. The crosspeak pattern
observed matches precisely that predicted for retention of the 
bulge in solution. All three NOEs that are uniquely characteristic
of the presence of the  bulge in solution are clearly observed in
the spectrum, whereas those characteristic of the crystal struc-
ture presented here are absent. Notably, the peak observed for
Fig. 3. Schematic diagram showing the pattern of NH-NH and CH-CH NOEs
predicted for conformations of MH2m (a) lacking and (b) containing thebulge
involving residues 53 and 54. CH-CH region (c) and NH-NH region (d) of a 1H-1H
NOESYspectrumofMH2macquiredatpH5.7,37°C, inD2OandH2O,respectively.
Crosspeaks consistent with the presence of the  bulge in solution are marked in
bold and underlined. Crosspeaks expected were MH2m to adopt a conformation
in solution identical to that in a are shown as solid circles.
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5166 is of similar intensity to those from residues in other
regions of the protein that are known to be highly structured in
solution (20). The data indicate, therefore, that the major
proportion of MH2m in solution under the conditions used to
crystallize the protein adopts a conformation in which the 
bulge involving residues 53 and 54 persists.
Resonances from residues 54, 57, and 58 are missing from the
two-dimensional total correlation spectroscopy spectrum of
MH2m at pH 5.7. In addition, the 1H-15N HSQC spectrum of
MH2m at pH 5.7 shows significant line broadening for residues
55 and 56 (data not shown). Consistent with previous observa-
tions (20, 21), our data suggest that these residues, which lie in
strand D2 in the crystal structure of HLA2m and in the
C-terminal region of strand D in MH2m, are in intermediate
exchange between different conformations in solution, one of
which presumably includes the continuous  strand involving
residues 51–56 observed here by crystallography. The NMR data
described here indicate, therefore, that at least the vast majority
of molecules of MH2m in solution adopt a structure distinct
from that observed in the crystal structure presented here,
indicating that a rare conformation of monomeric 2m in
solution can form a stable crystal lattice that displaces the
equilibrium toward this state.
Implications for Amyloid Formation. Previous data on a number of
proteins, including MH2m, have suggested that partial unfold-
ing is a prerequisite for the assembly of native proteins into
amyloid fibrils (5–8). Our previous experiments on MH2m have
suggested that the amyloid precursor state formed at pH 3.6
retains a native-like core involving strands C, D, E, and F that
comprise the central Greek key domain in the native protein,
whereas the precursor formed at lower pH (pH 2.5) is more
highly unfolded (8, 10, 31). Interestingly, the N- and C-terminal
regions of the polypeptide, which form  strands A and G in the
native protein, are highly destabilized in the amyloid precursor
conformation at pH 3.6 and are also relatively weakly protected
from hydrogen exchange in the amyloid fibril (31, 35). Despite
the rapid increase in our knowledge of the conformation of the
amyloid precursors of MH2m formed at low pH (8, 10, 31), little
is known about the manner by which these precursor states
assemble into amyloid. Moreover, the structural characteristics
and assembly mechanism of the amyloid precursor populated
from the intact protein at physiological pH are also relatively
poorly understood (13, 15). The data presented here provide
important new clues into these questions. Ordered assembly is
most likely to occur by the association of preformed comple-
mentary surfaces (18). Our data suggest that the long straight
conformation of strand D in the crystal structure of MH2m
could provide such a surface. Although an increase in confor-
mational dynamics in this region, caused by dissociation of 2m
from the heavy chain of the HLA, could be involved in the
initiation of amyloid fibril formation (20, 21), we propose that
the ordering of strand D to the conformation observed here by
crystallography could provide a template for the propagation of
ordered assembly. This rarely populated conformation of 2m
offers a rationale for the observation that at pH 5 and above,
fibrils of full length 2m are formed only at very high concen-
trations (14), or in the presence of copper ions (13), and involve
a rarely populated state that is capable of extending preexisting
fibrillar material (15).
How could the structural rearrangements in strand D facilitate
assembly? In a recent study, Richardson and Richardson (18)
have identified features common to  sheet proteins that may
have evolved to prevent aggregation. One such feature, often
found in the edge strands of  sheet-containing proteins, is the
presence of a twisted or bulged edge strand. Such features are
proposed to disfavor edge strand docking (see Table 2, which is
published as supporting information on the PNAS web site). By
contrast, long (6 residues) regular  strands at the edges of 
sheets are proposed to favor edge-to-edge strand association
between adjacent monomers, so that their hydrogen-bonding
potential can be satisfied. A second common feature, often
observed in  sandwich proteins involves protection of one or
more of the edge  strands from intermolecular self association
by the possession of an inwardly pointing charged side chain,
which would be buried by dimerization. Indeed, the addition of
only a single lysine to the edge of de novo designed  sheet
proteins has been shown to inhibit polymerization into amyloid
fibrils (36).
Monomeric 2m possesses four edge strands; strands A and G
form one edge pair, whereas strands C and D form the second
edge strand pair (Fig. 1). Strands A and G are protected in both
HLA2m and MH2m by an inwardly pointing charge contrib-
uted by Lys-91 in strand G. The short  strands D1 and D2
separated by a  bulge provide an excellent mechanism for
prohibiting self assembly at the other edge of the  sandwich.
However, the conformation of  strand D observed here in the
crystal structure of MH2m provides an ideal assembly surface,
making this edge-strand pair vulnerable to aggregation. For the
crystal structure shown here, the hydrogen-bonding potential of
strand D is satisfied by the formation of intermolecular inter-
actions with adjacent molecules within the lattice, demonstrating
the potential for this region to propagate assembly through
edge-strand interactions. In addition, the changes observed in
strand D result in different orientations of the side chains of
residues 50–54. This arises because of the i to i  1 slippage in
the hydrogen-bond pairings in this strand. As a result, His-51
(which points inwards in the structure of HLA2m) rotates by
approximately 180°, such that it now points away from the
hydrophobic core of the protein. This would remove the second
protective feature from the edge strand, facilitating further
interaction in this region (His-51 would be at least partially
charged at pH 7.0 and below) (Fig. 4).
Whatever the origin of intermolecular associations, it is clear
that further conformational changes are required to promote
assembly of adjacent monomers into amyloid fibrils. Such
changes are likely to include the fraying of the N- and C-terminal
strands, which would expose new assembly-competent sites (12,
31, 35). The structure of MH2m identified here by crystalliza-
tion suggests that the reorganization of strand D and the
resulting loss of the protective features in this region could
Fig. 4. Ribbon diagram showing the position of His-51 in the crystal struc-
tures of (a) MH2m and (b) HLA2m. Note that in a, His-51 is outwardly
pointing, whereas in b, this residue points inward. Drawn by using SPOCK (39).
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provide one such site. Ongoing studies aim to provide a quan-
titative estimate of the populations and interconversions be-
tween the observed conformational states of human 2m and to
test the hypothesis that specific rare conformations are involved
in amyloid assembly under physiological conditions. The data
presented here support the suggestion of Richardson and Rich-
ardson (18) that alteration of  sheet edge strands could be a
critical first step in the formation of amyloid.
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